Benitec Biopharma Inc.
BNTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001808898
No open-market purchases or sales by Benitec Biopharma Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $443.3M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Benitec Biopharma Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 17 | 12 | −5 |
| SharesConverted for a 1-for-17 split | 650.4K | 1.27M | +617.6K (+95.0%) |
| Value | $2.45M | $3.84M | +$1.38M (+56.4%) |
New holders (3)
Institutions that held Benitec Biopharma Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Janus Henderson Group PLC | 206,170 | $630.9K | 0.00% |
| Adage Capital Partners GP, L.L.C. | 189,188 | $571.7K | 0.00% |
| Citadel Advisors LLC | 69,515 | $209.9K | 0.00% |
Sold out (8)
Institutions that held Benitec Biopharma Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Vanguard Group Inc | 74,773 | $17.8K |
| Virtu Financial LLC | 52,869 | $13.0K |
| Morgan Stanley | 38,600 | $9.21K |
| State Street Corp | 21,438 | $5.11K |
| Private Advisor Group, LLC | 13,157 | $3.14K |
| WealthTrust Axiom LLC | 12,950 | $3.09K |
| Northern Trust Corp | 11,813 | $2.82K |
| Cutler Group LP | 1,000 | $0 |